|
DE60138535D1
(de)
|
2000-02-04 |
2009-06-10 |
Children S Hospital Res Founda |
Verwendung von lysosomal acid lipase zur behandlung von atherosklerose und ähnlichen krankheiten
|
|
WO2010045659A1
(en)
|
2008-10-17 |
2010-04-22 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
KR101742346B1
(ko)
|
2010-04-23 |
2017-06-15 |
시나게바 바이오파르마, 코포레이션 |
리소솜 축적병 효소
|
|
US9309534B2
(en)
|
2010-07-12 |
2016-04-12 |
Universidad Autonoma De Barcelona |
Gene therapy composition for use in diabetes treatment
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
BR122019021757B1
(pt)
|
2010-09-09 |
2020-12-08 |
Alexion Pharmaceuticals, Inc |
composição farmacêutica para tratamento de um paciente humano sofrendo de uma deficiência de lipase ácida lisossomal (lal)
|
|
EP2857499A1
(en)
|
2010-10-01 |
2015-04-08 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2675472A4
(en)
|
2011-02-15 |
2014-09-17 |
Synageva Biopharma Corp |
METHOD FOR THE TREATMENT OF LACK OF LYSOSOMAL SAURER LIPASE
|
|
JP6091435B2
(ja)
|
2011-02-22 |
2017-03-08 |
カリフォルニア インスティチュート オブ テクノロジー |
アデノ随伴ウイルス（ａａｖ）ベクターを用いたタンパク質の送達
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
PT3682905T
(pt)
|
2011-10-03 |
2022-04-07 |
Modernatx Inc |
Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
|
|
ES2923757T3
(es)
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
WO2013130393A1
(en)
*
|
2012-02-28 |
2013-09-06 |
Cornell University |
Aav-directed persistent expression of an anti-nicotine antibody gene for smoking cessation
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US10004811B2
(en)
*
|
2012-04-13 |
2018-06-26 |
Cornell University |
Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
|
|
WO2014052693A2
(en)
|
2012-09-29 |
2014-04-03 |
The Trustees Of The University Of Pennsylvania |
Veterinary composition and methods for non-surgical neutering and castration
|
|
EP2914731B1
(en)
*
|
2012-11-01 |
2019-09-11 |
California Institute of Technology |
Reversible gene expression
|
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
|
EP2931318A4
(en)
*
|
2012-12-13 |
2016-07-20 |
Univ Pennsylvania |
DNA ANTIBODY CONSTRUCTS AND METHODS FOR USE THEREOF
|
|
PL2931304T3
(pl)
|
2012-12-13 |
2021-11-08 |
The Trustees Of The University Of Pennsylvania |
Szczepionka wt1
|
|
WO2014120975A1
(en)
|
2013-02-01 |
2014-08-07 |
California Institute Of Technology |
Antibody-mediated immunocontraception
|
|
US11332719B2
(en)
*
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US9597658B2
(en)
|
2013-04-01 |
2017-03-21 |
Savannah River Nuclear Solutions, Llc |
Metal-organic framework templated synthesis of porous inorganic materials as novel sorbents
|
|
WO2014186746A1
(en)
*
|
2013-05-16 |
2014-11-20 |
University Of Florida Research Foundation, Inc. |
HAIRPIN mRNA ELEMENTS AND METHODS FOR THE REGULATION OF PROTEIN TRANSLATION
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
SG11201604719WA
(en)
|
2013-12-13 |
2016-07-28 |
Univ Pennsylvania |
Dna antibody constructs and method of using same
|
|
US9884075B2
(en)
|
2014-01-16 |
2018-02-06 |
California Institute Of Technology |
Domain-swap T cell receptors
|
|
US10612041B2
(en)
|
2014-03-21 |
2020-04-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Genome editing without nucleases
|
|
CR20160519A
(es)
|
2014-05-13 |
2017-01-27 |
The Trustees Of The Univ Of Pennysylvania |
Composiciones que comprenden avv que expresa constructos de anticuerpos duales y sus usos
|
|
CN107043774B
(zh)
*
|
2014-09-25 |
2021-05-04 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种嵌合强启动子及其用途
|
|
EP3215191B1
(en)
|
2014-11-05 |
2024-08-14 |
Voyager Therapeutics, Inc. |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
KR20230145206A
(ko)
|
2014-11-14 |
2023-10-17 |
보이저 테라퓨틱스, 인크. |
조절성 폴리뉴클레오티드
|
|
WO2016089862A1
(en)
|
2014-12-01 |
2016-06-09 |
The Trustees Of The University Of Pennsylvania |
Dna antibody constructs and method of using same
|
|
EP3242945B1
(en)
|
2015-01-07 |
2021-09-01 |
Universitat Autònoma de Barcelona |
Single-vector gene construct comprising insulin and glucokinase genes
|
|
US11000597B2
(en)
*
|
2015-01-21 |
2021-05-11 |
University Of Florida Research Foundation, Incorporated |
Engineered receptor/ligand system for delivery of therapeutic agents
|
|
CN107427666B
(zh)
|
2015-01-30 |
2022-11-04 |
加利福尼亚大学校董 |
脊髓软膜下基因递送系统
|
|
CN115094062A
(zh)
|
2015-04-16 |
2022-09-23 |
埃默里大学 |
用于肝脏中蛋白质表达的重组启动子和载体及其用途
|
|
SI3288379T1
(sl)
|
2015-05-01 |
2022-06-30 |
Onl Therapeutics, Inc. |
Peptidne sestave in načini uporabe
|
|
CA2984629C
(en)
|
2015-05-07 |
2024-06-18 |
University Of South Florida |
Modified ube3a gene for a gene therapy approach for angelman syndrome
|
|
WO2016200543A2
(en)
|
2015-05-13 |
2016-12-15 |
The Trustees Of The University Of Pennsylvania |
Aav-mediated expression of anti-inluenza antibodies and methods of use thereof
|
|
US10016514B2
(en)
|
2015-05-15 |
2018-07-10 |
New Hope Research Foundation |
Polynucleotides, vectors and methods for insertion and expression of transgenes
|
|
US10966414B2
(en)
|
2015-05-26 |
2021-04-06 |
California Institute Of Technology |
Population control using engineered translocations
|
|
US11980663B2
(en)
|
2015-07-08 |
2024-05-14 |
American Gene Technologies International Inc. |
HIV pre-immunization and immunotherapy
|
|
WO2017023708A1
(en)
|
2015-07-31 |
2017-02-09 |
California Institute Of Technology |
Activity-dependent expression of nucleic acids
|
|
AU2016366549B2
(en)
|
2015-12-11 |
2022-11-10 |
California Institute Of Technology |
Targeting peptides for directing adeno-associated viruses (AAVs)
|
|
IL297238B2
(en)
|
2016-01-15 |
2024-08-01 |
American Gene Tech Int Inc |
Methods and preparations for gamma-delta T-cell activation
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
JP7153332B2
(ja)
|
2016-02-08 |
2022-10-14 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
Ｈｉｖワクチン接種および免疫療法
|
|
ES2911448T3
(es)
|
2016-03-09 |
2022-05-19 |
American Gene Tech Int Inc |
Vectores combinados y métodos para el tratamiento del cáncer
|
|
US20230279434A1
(en)
*
|
2016-03-31 |
2023-09-07 |
University Of Cincinnati |
Methods and compositions for the treatment of als
|
|
IL262207B2
(en)
*
|
2016-04-15 |
2026-01-01 |
Univ Pennsylvania |
Preparations for the treatment of wet age-related macular degeneration
|
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
WO2017189963A1
(en)
*
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
WO2017213697A1
(en)
|
2016-06-08 |
2017-12-14 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
|
CA3028982A1
(en)
|
2016-07-08 |
2018-01-11 |
American Gene Technologies International Inc. |
Hiv pre-immunization and immunotherapy
|
|
WO2018017882A1
(en)
|
2016-07-21 |
2018-01-25 |
American Gene Technologies International Inc. |
Viral vectors for treating parkinson's disease
|
|
US20190160187A1
(en)
*
|
2016-07-26 |
2019-05-30 |
Cornell University |
Gene therapy for the treatment of aldehyde dehydrogenase deficiency
|
|
CN106434575A
(zh)
*
|
2016-09-26 |
2017-02-22 |
中国动物卫生与流行病学中心 |
流感病毒作为表达载体的构建方法
|
|
EP3519431A1
(en)
|
2016-09-28 |
2019-08-07 |
Cohbar Inc. |
Therapeutic mots-c related peptides
|
|
WO2018060288A1
(en)
|
2016-09-29 |
2018-04-05 |
Glaxosmithkline Biologicals S.A. |
Compositions and methods of treatment of persistent hpv infection
|
|
CN109996809A
(zh)
|
2016-11-14 |
2019-07-09 |
诺华股份有限公司 |
与促融合蛋白minion相关的组合物、方法和治疗用途
|
|
US11564944B2
(en)
*
|
2016-11-21 |
2023-01-31 |
Nant Holdings Ip, Llc |
Fractal combination therapy
|
|
JP7118062B2
(ja)
|
2016-12-09 |
2022-08-15 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
リサウイルス抗原を有するチンパンジーアデノウイルス構築物
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
CA3087881A1
(en)
|
2017-01-17 |
2018-07-26 |
Michael David FORREST |
Therapeutic inhibitors of the reverse mode of atp synthase
|
|
US11117930B2
(en)
|
2017-02-23 |
2021-09-14 |
Adrx, Inc. |
Peptide inhibitors of transcription factor aggregation
|
|
RS65241B1
(sr)
|
2017-02-28 |
2024-03-29 |
Univ Pennsylvania |
Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
TW201837170A
(zh)
|
2017-02-28 |
2018-10-16 |
賓州大學委員會 |
新穎ａａｖ媒介的流感疫苗
|
|
MA47820A
(fr)
*
|
2017-03-10 |
2020-01-15 |
Genethon |
Traitement de la glycogénose de type iii
|
|
US11820999B2
(en)
|
2017-04-03 |
2023-11-21 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
CA3059891A1
(en)
|
2017-04-14 |
2018-10-18 |
National Taiwan University |
Gene therapy for aadc deficiency
|
|
WO2018226992A1
(en)
|
2017-06-07 |
2018-12-13 |
Adrx, Inc. |
Tau aggregation inhibitors
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
US12559769B2
(en)
|
2017-06-16 |
2026-02-24 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells
|
|
CA3068010A1
(en)
*
|
2017-06-20 |
2018-12-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Codon-optimized human npc1 genes for the treatment of niemann-pick type c1 deficiency and related conditions
|
|
CA3068304A1
(en)
*
|
2017-06-28 |
2019-01-03 |
University Of South Florida |
Modified ube3a gene for a gene therapy approach for angelman syndrome
|
|
CA3099077A1
(en)
|
2017-07-13 |
2019-01-17 |
Michael David FORREST |
Therapeutic modulators of the reverse mode of atp synthase
|
|
EP3655539A1
(en)
|
2017-07-21 |
2020-05-27 |
GlaxoSmithKline Biologicals S.A. |
Chikungunya virus antigen constructs
|
|
BR112020001060A2
(pt)
|
2017-07-27 |
2020-07-14 |
Novartis Ag |
variantes de trem2 resistentes a shedase
|
|
US11512327B2
(en)
|
2017-08-03 |
2022-11-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of AAV
|
|
MX2020001593A
(es)
*
|
2017-08-09 |
2020-07-13 |
Bioverativ Therapeutics Inc |
Moleculas de acido nucleico y usos de las mismas.
|
|
SG11202003058UA
(en)
|
2017-10-16 |
2020-04-29 |
Glaxosmithkline Biologicals Sa |
Replication competent adenoviral vectors
|
|
US20200299651A1
(en)
|
2017-10-16 |
2020-09-24 |
Glaxosmithkline Biologicals Sa |
Simian adenoviral vectors with two expression cassettes
|
|
US11859199B2
(en)
|
2017-10-16 |
2024-01-02 |
Glaxosmithkline Biologicals Sa |
Adenoviral vectors with two expression cassettes encoding RSV antigenic proteins or fragments thereof
|
|
MX394509B
(es)
|
2017-10-16 |
2025-03-12 |
Glaxosmithkline Biologicals Sa |
Promotor mejorado
|
|
AU2018354195A1
(en)
*
|
2017-10-23 |
2020-06-04 |
Prevail Therapeutics, Inc. |
Gene therapies for neurodegenerative disease
|
|
US20200283800A1
(en)
*
|
2017-10-23 |
2020-09-10 |
Prevail Therapeutics, Inc. |
Gene therapies for neurodegenerative diseases
|
|
CA3086045A1
(en)
|
2017-12-19 |
2019-06-27 |
Akouos, Inc. |
Aav-mediated delivery of therapeutic antibodies to the inner ear
|
|
KR20200101394A
(ko)
|
2017-12-20 |
2020-08-27 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
엡스타인-바 바이러스 항원 구축물
|
|
CN108103104B
(zh)
*
|
2017-12-21 |
2021-07-06 |
北京锦篮基因科技有限公司 |
一种预防和治疗脉络膜新生血管相关眼部疾病的基因药物
|
|
JP7569216B2
(ja)
|
2018-01-17 |
2024-10-17 |
アドリーナス セラピューティクス， インコーポレイテッド |
２１－ヒドロキシラーゼ欠損症のためのアデノ随伴ウイルス遺伝子療法
|
|
AU2019221642A1
(en)
*
|
2018-02-14 |
2020-07-09 |
Generation Bio Co. |
Non-viral DNA vectors and uses thereof for antibody and fusion protein production
|
|
US11738093B2
(en)
|
2018-04-09 |
2023-08-29 |
Hope For Annabel |
AAV-mediated delivery of ATP1A3 genes to central nervous system
|
|
CA3098807A1
(en)
*
|
2018-05-08 |
2019-11-14 |
Neuracle Science Co., Ltd. |
Adeno-associated virus (aav) delivery of anti-fam19a5 antibodies
|
|
CN112424359A
(zh)
|
2018-05-15 |
2021-02-26 |
沃雅戈治疗公司 |
用于治疗帕金森氏病的组合物和方法
|
|
WO2019222329A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
WO2019222444A2
(en)
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Directed evolution
|
|
MX2020013553A
(es)
|
2018-06-12 |
2021-02-26 |
Glaxosmithkline Biologicals Sa |
Polinucleotidos y polipeptidos de adenovirus.
|
|
WO2020019002A1
(en)
*
|
2018-07-20 |
2020-01-23 |
University Of Utah Research Foundation |
Gene therapy for macular degeneration
|
|
JP7602454B2
(ja)
|
2018-08-09 |
2024-12-18 |
バイオベラティブ セラピューティクス インコーポレイテッド |
核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
|
|
US11858969B2
(en)
|
2018-09-18 |
2024-01-02 |
California Institute Of Technology |
Engineered light-sensitive proteins
|
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
US20210371470A1
(en)
|
2018-10-12 |
2021-12-02 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
EP3876952A4
(en)
|
2018-11-05 |
2022-08-24 |
American Gene Technologies International Inc. |
VECTOR SYSTEM FOR EXPRESSING REGULATORY RNA
|
|
US11965172B2
(en)
|
2018-11-05 |
2024-04-23 |
California Institute Of Technology |
DNA sequence modification-based gene drive
|
|
US20200148762A1
(en)
*
|
2018-11-09 |
2020-05-14 |
Avamab Pharma Inc. |
Methods for regulating endogenous production of antibodies against infectious diseases
|
|
EP3886898A4
(en)
|
2018-12-01 |
2022-08-24 |
International AIDS Vaccine Initiative |
RECOMBINANT HIV ENV POLYPEPTIDES AND THEIR USE
|
|
CN113423419A
(zh)
*
|
2019-01-04 |
2021-09-21 |
桑格摩生物治疗股份有限公司 |
用于治疗法布里病的方法和组合物
|
|
WO2020150065A1
(en)
|
2019-01-14 |
2020-07-23 |
California Institute Of Technology |
Methods and compositions for modulating appetite and intake of sodium
|
|
CA3125770A1
(en)
|
2019-01-18 |
2020-07-23 |
Voyager Therapeutics, Inc. |
Methods and systems for producing aav particles
|
|
SG11202107761SA
(en)
|
2019-01-28 |
2021-08-30 |
Cohbar Inc |
Therapeutic peptides
|
|
US12582724B2
(en)
|
2019-02-20 |
2026-03-24 |
Duke University |
Compositions comprising microbial polypeptides for degrading glycogen and methods for the treatment of glycogen storage diseases
|
|
MA55321A
(fr)
|
2019-03-15 |
2022-01-19 |
Modernatx Inc |
Vaccins à base d'arn contre le vih
|
|
WO2020243659A1
(en)
*
|
2019-05-31 |
2020-12-03 |
University Of Florida Research Foundation, Incorporated |
Vector-based therapy for thyroid disease
|
|
CN113966228A
(zh)
|
2019-06-11 |
2022-01-21 |
葛兰素史密斯克莱生物公司 |
黏膜疫苗配制剂
|
|
US20230038502A1
(en)
|
2019-06-11 |
2023-02-09 |
Shire Human Genetic Therapies, Inc. |
Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein
|
|
CN110423778B
(zh)
*
|
2019-07-26 |
2023-04-21 |
上海科技大学 |
一种逆行性重组2型腺相关病毒在感染螺旋神经元中的应用
|
|
WO2021030745A1
(en)
*
|
2019-08-15 |
2021-02-18 |
The Children's Hospital Of Philadelphia |
Combined transgene and intron-derived mirna therapy for treatment of sca1
|
|
WO2021046155A1
(en)
|
2019-09-03 |
2021-03-11 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
|
WO2021081280A1
(en)
|
2019-10-23 |
2021-04-29 |
Shire Human Genetic Therapies, Inc. |
Adeno-associated virus vectors based gene therapy for hereditary angioedema
|
|
CN116096904A
(zh)
*
|
2019-12-31 |
2023-05-09 |
天鹅生物疗法有限公司 |
改进的aav-abcd1构建体和用于治疗或预防肾上腺脑白质营养不良(ald)和/或肾上腺脊髓神经病(amn)的用途
|
|
WO2021169167A1
(en)
*
|
2020-02-29 |
2021-09-02 |
Nanjing GenScript Biotech Co., Ltd. |
Method for treating coronavirus infections
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
|
CN111705069A
(zh)
*
|
2020-06-19 |
2020-09-25 |
武汉纽福斯生物科技有限公司 |
一种多神经营养因子联合表达载体及其应用
|
|
US20230285596A1
(en)
|
2020-07-27 |
2023-09-14 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
|
BR112023001456A2
(pt)
|
2020-07-27 |
2023-04-11 |
Voyager Therapeutics Inc |
Composições e métodos para o tratamento de distúrbios neurológicos relacionados à deficiência de beta glicosilceramidase
|
|
EP4214242A1
(en)
*
|
2020-09-15 |
2023-07-26 |
RegenxBio Inc. |
Vectorized antibodies for anti-viral therapy
|
|
WO2022098906A1
(en)
*
|
2020-11-04 |
2022-05-12 |
The Trustees Of The University Of Pennsylvania |
Viral vectors encoding canine insulin for treatment of metabolic diseases in dogs
|
|
IL303317A
(en)
|
2020-12-01 |
2023-07-01 |
Akouos Inc |
ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA
|
|
EP4263614A1
(en)
|
2020-12-16 |
2023-10-25 |
Takeda Pharmaceutical Company Limited |
Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein
|
|
US20250325469A1
(en)
|
2021-01-24 |
2025-10-23 |
Michael David FORREST |
Inhibitors of atp synthase - cosmetic and therapeutic uses
|
|
AU2022214529A1
(en)
*
|
2021-02-01 |
2023-08-03 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of niemann pick type a disease
|
|
EP4306131A4
(en)
|
2021-03-08 |
2025-06-18 |
Nanjing GenScript Biotech Co., Ltd. |
ANTIBODY DELIVERY USING A DUAL VIRAL VECTOR SYSTEM
|
|
CA3212876A1
(en)
|
2021-03-19 |
2022-09-22 |
Adrenas Therapeutics, Inc. |
Gene therapies for 21-hydroxylase deficiency
|
|
IL310597A
(en)
*
|
2021-08-06 |
2024-04-01 |
Univ Pennsylvania |
Preparations and methods for the treatment and prevention of misfolded proteins
|
|
PE20241891A1
(es)
*
|
2021-09-01 |
2024-09-19 |
Jaguar Gene Therapy Llc |
Vectores y viriones adenoasociados para tratar la galactosemia y metodos de uso y fabricacion
|
|
CN117535291A
(zh)
*
|
2021-09-08 |
2024-02-09 |
北京锦篮基因科技有限公司 |
一种高表达活性的组成型启动子及其应用
|
|
AU2022366947A1
(en)
|
2021-10-12 |
2024-05-02 |
Bridgebio Gene Therapy Llc |
Methods and compositions for treating leukodystrophies
|
|
CN114085816B
(zh)
*
|
2021-10-26 |
2023-05-26 |
四川大学华西医院 |
一种标记临近星形胶质细胞的方法
|
|
CN114107390B
(zh)
*
|
2021-11-05 |
2023-10-24 |
中国科学院精密测量科学与技术创新研究院 |
一种用于表达抗体IgG1的rAAV载体及其应用
|
|
US20250049955A1
(en)
|
2021-11-17 |
2025-02-13 |
Voyager Therapeutics, Inc. |
Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
EP4507719A1
(en)
|
2022-04-13 |
2025-02-19 |
Universitat Autònoma de Barcelona |
Treatment of neuromuscular diseases via gene therapy that expresses klotho protein
|
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
|
WO2023248147A1
(en)
|
2022-06-21 |
2023-12-28 |
Crispr Therapeutics Ag |
Methods and compositions for in vivo editing of stem cells
|
|
WO2023248145A1
(en)
|
2022-06-21 |
2023-12-28 |
Crispr Therapeutics Ag |
Compositions and methods for treating human immunodeficiency virus
|
|
CN116396983B
(zh)
*
|
2022-10-10 |
2026-05-26 |
苏州吉纳星辰生物技术有限公司 |
一种检测aav抗体滴度的方法
|
|
WO2024145474A2
(en)
|
2022-12-29 |
2024-07-04 |
Voyager Therapeutics, Inc. |
Compositions and methods for regulating mapt
|
|
AU2023427408A1
(en)
|
2023-02-02 |
2025-09-04 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
US20240398984A1
(en)
*
|
2023-05-22 |
2024-12-05 |
Fred Hutchinson Cancer Center |
Treatment of hsv-2 using a meganuclease
|
|
WO2025171001A1
(en)
|
2024-02-06 |
2025-08-14 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for improved production of aav viral vectors
|
|
CN118045206B
(zh)
*
|
2024-04-12 |
2024-07-05 |
四川至善唯新生物科技有限公司 |
一种治疗脊髓型肌肉萎缩的药物组合物及其用途
|